Small bile duct abnormalities in sarcoidosis.

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Sarcoidosis is a multisystem inflammatory disease.
• Hepatic involvement in sarcoidosis can present with diverse clinical and histological findings.
• Bile duct abnormalities are an under-recognized manifestation of liver sarcoidosis.

Purpose of the Study:

• To describe the clinical and histological features of hepatic sarcoidosis presenting with bile duct depletion.
• To evaluate the diagnostic utility of liver biopsy in identifying "ductopenia" in sarcoidosis.
• To assess the impact of steroid therapy on bile duct depletion in affected patients.

Main Methods:

• Case series of four patients with biopsy-proven hepatic sarcoidosis.
• Clinical data collection including symptoms and laboratory tests (alkaline phosphatase, aspartate aminotransferase).
• Review of endoscopic retrograde cholangiopancreatography (ERCP) findings and detailed liver biopsy analysis focusing on bile duct quantification and fibrosis.

Main Results:

• All four patients presented with fever, weight loss, anorexia, elevated alkaline phosphatase, and mild aspartate aminotransferase abnormalities.
• Liver biopsies revealed significant bile duct depletion (10-100% absence), correlating with the degree of hepatic fibrosis.
• ERCP showed minor intrahepatic irregularities, insufficient for diagnosing sclerosing cholangitis.

Conclusions:

• Bile duct depletion is a key histological feature of hepatic sarcoidosis, termed "ductopenia".
• Quantifying bile duct loss in liver biopsies is a valuable diagnostic marker for sarcoid liver disease.
• Corticosteroid treatment improves sarcoidosis symptoms but does not halt the progression of ductopenia.